Cargando…
Point-of-care cell therapy manufacturing; it’s not for everyone
The use of cellular therapies to treat cancer, inherited immune deficiencies, hemoglobinopathies and viral infections is growing rapidly. The increased interest in cellular therapies has led to the development of reagents and closed-system automated instruments for the production of these therapies....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761342/ https://www.ncbi.nlm.nih.gov/pubmed/35033098 http://dx.doi.org/10.1186/s12967-022-03238-5 |